Results 241 to 250 of about 28,421 (276)

p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death

open access: diamond
Koji Demiya   +14 more
openalex   +1 more source

Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape. [PDF]

open access: yesWorld J Gastrointest Oncol
Xiao R   +5 more
europepmc   +1 more source

SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis. [PDF]

open access: yesBiomark Res
Chen F   +8 more
europepmc   +1 more source

Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer. [PDF]

open access: yesJ Immunother Cancer
Guo X   +13 more
europepmc   +1 more source

Personalizing Oncolytic Virotherapy

open access: yesHuman Gene Therapy, 2023
The use of oncolytic viruses has become an attractive tool in the clinics for the treatment of various tumor types. Such viruses are genetically modified to conditionally replicate in malignant cells while unharming healthy cells.
Firas Hamdan, M. Fusciello, V. Cerullo
semanticscholar   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Oncolytic Virotherapy.

Cancer treatment and research, 2023
Oncolytic virotherapy opens up avenues for cancer treatment by selectively targeting the cancer cells and destructs them either through direct lysis or by inducing an immune response in the tumor microenvironment. This platform technology utilizes a diverse range naturally existing or genetically modified oncolytic viruses for their immunotherapeutic ...
M. Fatima, D. Amraiz, M. Navid
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy